Heidelberg Innovation Fonds Management GmbH Company Profile

07:42 EDT 18th June 2018 | BioPortfolio

Heidelberg Innovation invests exclusively in Healthcare companies. Focussing on Medical Devices and Specialty Pharma, the firm is recognized as one of the leading venture capital companies specialized in these sectors. The firm was founded in 1997.With over 50 years of combined experience in the industry, the team currently manages a total of € 125m in three funds.
Heidelberg Innovation employs its in-house know-how in cooperation with a competent, international network to support the successful growth of the portfolio companies.
The thorough selection of investment opportunities in Medical Devices and Specialty Pharma enables Heidelberg Innovation to do successful investments in the most lucrative and strongly growing markets of the Healthcare sector.


Im Neuenheimer Feld 581


Phone: 49-6221 - 64 68 0

News Articles [1201 Associated News Articles listed on BioPortfolio]

Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab

Bad Marienberg - Die Heidelberg Pharma AG (ISIN DE000A11QVV0/ WKN A11QVV) gab heute den Abschluss eines Lizenzvertrags zwischen ihrer Tochtergesellschaft Heidelberg Pharma Research GmbH und der Uni...

Heidelberg Pharma: Lizenz- und Forschungsdeal mit Magenta Therapeutics

Heidelberg Pharma hat mit Magenta Therapeutics eine Kooperation im Bereich der Wirkstoffforschung vereinbart. "Heidelberg Pharma Research GmbH unterzeichnete die Vereinbarung, bei der aus Magentas ...

Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement

Heidelberg Pharma AG and Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, announced the si...

Heidelberg Pharma: Anfang 2019 wird es spannend - Exklusiv-Interview

Nach zwei Kapitalerhöhungen ist Heidelberg Pharma bis 2020 durchfinanziert. Im Exklusivinterview mit der Redaktion von erläutert Jan Schmidt-Brand, Vorstandschef von Heidelberg Ph....

L'université de Tel Aviv crée un fonds de capital-risque

Le fonds exploitera différents programmes d'incubation, aux côtés de partenaires stratégiques, dans divers domaines technologiques. Le premier programme se déroule avec NEC, géant japonais, et...

Bachmann Welser, financiers de projet/commerce international, vont lancer un fonds de ...

     (Logo: Le lancement coïncidera avec l'ouverture du siège de Bachmann & Welser à Hong Kong. Le fonds,...

"Mister Makro" verlässt J.P. Morgan Asset Management

Wien - Portfoliomanager Talib Sheikh wird J.P. Morgan Asset Management verlassen, so die Experten von "FONDS professionell".Er wolle sich "neuen beruflichen Herausforderungen" stellen, heiße es in .....

DGAP-Gesamtstimmrechtsmitteilung: Heidelberg Pharma AG (deutsch)

Heidelberg Pharma AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Heidelberg Pharma AG / Veröffentlic....

PubMed Articles [2082 Associated PubMed Articles listed on BioPortfolio]

Impact of the choice of reference genome on the ability of the core genome SNV methodology to distinguish strains of Salmonella enterica serovar Heidelberg.

Salmonella enterica serovar Heidelberg (S. Heidelberg) is one of the top serovars causing human salmonellosis. The core genome single nucleotide variant pipeline (cgSNV) is one of several whole genome...

The CNO and Leading Innovation: Competencies for the Future.

Although innovation is critical to success in today's tumultuous environment, health care is slow to embrace it, and there is significant variability in strategic adoption of innovation across organiz...

Relationship between lean practices, soft total quality management and innovation skills in Lebanese hospitals.

Lean practices are critical to eliminate waste and enhance the quality of healthcare services through different improvement approaches of total quality management (TQM). In particular, the soft side o...

Harnessing Technology Innovation to Improve Patient Care.

Defining Innovation in Neurosurgery: Results from an International Survey.

Innovation is a part of the daily practice of neurosurgery. A clear definition of what constitutes innovation is currently lacking, however, and opinions vary from continent to continent, from hospita...

Clinical Trials [2589 Associated Clinical Trials listed on BioPortfolio]

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

Eligible patients underwent evaluation of ocular surface parameters by Ocular Surface Disease Index (OSDI) and Glaucoma Symptom Scale (GSS) questionnaires, Break Up Time test (BUT), Schirm...

How Well Does the Data Obtained From Heidelberg Edge Perimeter Visual Field Compare to Standard Octopus Visual Field

The purpose of this study is to compare standard automated perimetry (SAP) using the Heidelberg Edge Perimeter (HEP) with the Octopus Visual Field (OVF) analyzer and determine test-retest ...

Measuring Cyclotorsion on Scanning Laser Ophthalmoscopy (SLO)-Fundus Photographs

Pre-Study: Evaluation of the inter- and intrarater reliability of the integrated algorithm by Heidelberg Spectralis for measuring cyclotorsion on SLO-fundus fotographs, and assessment of t...

hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of ...

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS

Companies [2720 Associated Companies listed on BioPortfolio]

Heidelberg Innovation Fonds Management GmbH

Heidelberg Innovation invests exclusively in Healthcare companies. Focussing on Medical Devices and Specialty Pharma, the firm is recognized as one of the leading venture capital companies specialized...

Heidelberg Pharma GmbH

When working at Boehringer Mannheim (now Roche Diagnostics) from 1987 to 1999, the founders of Heidelberg Pharma, Dr. Dieter Herrmann and Dr. Hans-Georg Opitz, developed technologies and know-how that...

Technologiepark Heidelberg GmbH

International Science Park with focus on Life Sciences Located close to the University of Heidelberg and to international research institutes [for example: Deutsches Krebsforschungszentrum (DKFZ), E...

Oppenheim Pramerica Fonds Trust GmbH


Gene Bridges GmbH

Gene Bridges GmbH, founded 2000 as a spin-off of the European Molecular Biology Laboratories (EMBL), commercialises the patented Red/ET Recombineering technology. Gene Bridges GmbH Headquarters and ...

More Information about "Heidelberg Innovation Fonds Management GmbH" on BioPortfolio

We have published hundreds of Heidelberg Innovation Fonds Management GmbH news stories on BioPortfolio along with dozens of Heidelberg Innovation Fonds Management GmbH Clinical Trials and PubMed Articles about Heidelberg Innovation Fonds Management GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Heidelberg Innovation Fonds Management GmbH Companies in our database. You can also find out about relevant Heidelberg Innovation Fonds Management GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record